Evaluation of ERG Responsive Proteome in Prostate Cancer

BACKGROUND: Gene fusion between TMPRSS2 promoter and the ERG proto-oncogene is a major genomic alteration found in over half of prostate cancers (CaP), which leads to aberrant androgen dependent ERG expression. Despite extensive analysis for the biological functions of ERG in CaP, there is no system...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tan, Shyh-Han, Furusato, Bungo, Fang, Xueping, He, Fang, Mohamed, Ahmed A., Griner, Nicholas B., Sood, Kaneeka, Saxena, Sadhvi, Katta, Shilpa, Young, Denise, Chen, Yongmei, Sreenath, Taduru, Petrovics, Gyorgy, Dobi, Albert, McLeod, David G., Sesterhenn, Isabell A., Saxena, Satya, Srivastava, Shiv
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4075339/
https://ncbi.nlm.nih.gov/pubmed/24115221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22731
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak